There is no single "best" time to take a GLP-1 shot that works for everyone
We're a long way off being able to say that GLP-1 drugs such as Ozempic and Wegovy may reduce the risk of dementia, especially when the review only turned up two small in-human trials
Mild nausea or GI changes during this window are normal and usually resolve.
PubMed laboratory research record [PMID: 37375736] PubMed record related to this compound for laboratory literature review
Summary GLP-1 receptor agonists are definitely tools in the battle against obesity and type 2 diabetes, but I think of them as short-term meds, to give a person a head start, and help reduce weight quickly so that their heart isnt under such stress from being overweight
GLP-1s and more weigh in at ADA June 9, 2026 By Brian Orelli No Comments GLP-1 receptor agonists remained center stage at the 2026 Scientific Sessions of the American Diabetes Association with Boehringer Ingelheim GmbH and Astrazeneca plc, joining the leaders, Eli Lilly and Co